The Kras inhibitors market comprises drugs that specifically target mutations in the KRAS gene, which is one of the most common driver mutations found in various cancers like lung cancer and colorectal cancer. KRAS mutations are found in around 25% of all cancers and have traditionally proven difficult to directly target with existing drugs. However, recent breakthroughs in understand... https://www.zupyak.com/p/4480649/t/the-global-kras-inhibitors-market-is-anticipated-to-witness-high-growth-owing-to-rising-cancer-incidences